LMAT Stock Price - LeMaitre Vascular, Inc. logo

LMAT Stock Price

LeMaitre Vascular, Inc.

$83.16
+$0.54(+0.65%)
56
Overall
75
Value
30
Tech
65
Quality
How is this score calculated?
Market Cap
$1.89B
Volume
297.71K
52W Range
$78.22 - $118.01
Target Price
$107.43

LMAT stock price is $83.16 (+0.65% on the day), giving LeMaitre Vascular, Inc. a market cap of $1.89B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

LMAT Stock Overview

Price
$83.16
Previous close
$82.62
Open
$83.82
Market cap
$1.89B
P/E ratio
32.7
52-week range
$78.22 - $118.01
1-year price target
$107.43
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NSD
MarketXLS Rank
56

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It also provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular and porcine patches; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

ABCD
1SymbolPriceChangeVol
2LMAT$83.16+0.7%297.71K
3
4
5
6

Get LeMaitre Vascular, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.